Literature DB >> 3621676

Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.

S Fredrikson, P Eneroth, H Link.   

Abstract

Neopterin levels in cerebrospinal fluid (CSF) and serum were measured with a sensitive radioimmunoassay in patients with multiple sclerosis (MS), aseptic meningo-encephalitis (AM), other mostly non-inflammatory neurological diseases, and controls with tension headache or psychoneurosis. Elevated levels of neopterin were found in CSF in most patients during acute phase of AM, and normalization after clinical recovery. The elevation in CSF was not reflected in serum. Only four of 24 MS patients--three of them examined during exacerbation--had slight elevation of neopterin in CSF and all had normal serum levels. Neopterin levels in CSF correlated with mononuclear cell count. The elevation of neopterin observed in CSF in inflammatory CNS diseases despite low cell numbers in CSF compared to blood might reflect a high activation level of cells locally in the CNS. Neopterin in CSF is a valuable marker of acute cellular immune response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621676      PMCID: PMC1542575     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

2.  Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

Authors:  H Link; G Tibbling
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

3.  Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis.

Authors:  A B Noronha; D P Richman; B G Arnason
Journal:  N Engl J Med       Date:  1980-09-25       Impact factor: 91.245

4.  Urinary neopterin excretion in coeliac disease.

Authors:  D Fuchs; G Granditsch; A Hausen; G Reibnegger; H Wachter
Journal:  Lancet       Date:  1983-08-20       Impact factor: 79.321

5.  Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants.

Authors:  C Huber; D Fuchs; A Hausen; R Margreiter; G Reibnegger; M Spielberger; H Wachter
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

6.  Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases.

Authors:  R Margreiter; D Fuchs; A Hausen; C Huber; G Reibnegger; M Spielberger; H Wachter
Journal:  Transplantation       Date:  1983-12       Impact factor: 4.939

7.  Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.

Authors:  E L Reinherz; H L Weiner; S L Hauser; J A Cohen; J A Distaso; S F Schlossman
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

8.  [Increased urinary excretion of neopterin in patients with malignant tumors and with virus diseases (author's transl)].

Authors:  H Wachter; A Hausen; K Grassmayr
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-12

9.  Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients.

Authors:  H Link; V Kostulas
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

10.  Deficit of suppressor T cells in active multiple sclerosis.

Authors:  M A Bach; F Phan-Dinh-Tuy; E Tournier; L Chatenoud; J F Bach; C Martin; J D Degos
Journal:  Lancet       Date:  1980-12-06       Impact factor: 79.321

View more
  9 in total

1.  Immune-mediated mechanisms in multiple sclerosis.

Authors:  D Fuchs; G Reibnegger; E R Werner; H Wachter
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

2.  Cerebrospinal fluid and serum neopterin levels in patients with Lyme neuroborreliosis.

Authors:  L Dotevall; D Fuchs; G Reibnegger; H Wachter; L Hagberg
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

3.  Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals.

Authors:  A Ali; P Rudge; A G Dalgleish
Journal:  J Neurol       Date:  1992-05       Impact factor: 4.849

4.  Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission.

Authors:  C E Shaw; P R Dunbar; H A Macaulay; T J Neale
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

5.  Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D Donati; P Annunziata; G C Guazzi; D Boraschi; A Tagliabue
Journal:  Ital J Neurol Sci       Date:  1990-02

6.  Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.

Authors:  M Ott; L Demisch; W Engelhardt; P A Fischer
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

Review 7.  Neopterin in Diagnosis and Monitoring of Infectious Diseases.

Authors:  Michael Eisenhut
Journal:  J Biomark       Date:  2013-12-08

8.  Cerebrospinal fluid levels of neopterin are elevated in delirium after hip fracture.

Authors:  Roanna J Hall; Leiv Otto Watne; Ane-Victoria Idland; Johan Raeder; Frede Frihagen; Alasdair M J MacLullich; Anne Cathrine Staff; Torgeir Bruun Wyller; Durk Fekkes
Journal:  J Neuroinflammation       Date:  2016-06-29       Impact factor: 8.322

9.  Cerebrospinal fluid neopterin analysis in neuropediatric patients: establishment of a new cut off-value for the identification of inflammatory-immune mediated processes.

Authors:  Marta Molero-Luis; Sergio Fernández-Ureña; Iolanda Jordán; Mercedes Serrano; Aida Ormazábal; Àngels Garcia-Cazorla; Rafael Artuch
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.